Brainomix: Valuation, Funding & Investors
Brainomix develops AI-powered medical imaging solutions focused on stroke and lung fibrosis diagnosis and treatment support. The company offers FDA-cleared platforms, including Brainomix 360 Stroke and e-Lung, designed to assist hospitals and clinicians with advanced imaging and decision support.
Leadership & Board
- Current Number of Employees
- 89
- Current LinkedIn Followers
- 15,141
Latest Estimated Valuation
- Total Amount Raised
- $19M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $19M
- Latest Funding Round
- Series C
Company Momentum
PositiveBrainomix LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Brainomix had 89 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Brainomix had 15,141 followers as of November 2, 2026. The number of followers increased by 79 (0.52%) week-over-week.
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Feb 24, 2026 | Series C | $18.80M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Hostplus | Series C |
| Modi Ventures | Series C |
| Parkwalk | Series C |
Similar Companies
A snapshot of private companies similar to Brainomix, helping you discover and navigate related company profiles.
